Reduced heat shock proteins: a mechanism to explain higher cardiovascular events associated with doxazosin.
Hooper
P L
PL
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects* / Q000494:pharmacology*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000503:physiopathology*; D017292:Doxazosin / Q000009:adverse effects* / Q000494:pharmacology*; D006360:Heat-Shock Proteins / Q000502:physiology*; D006801:Humans
D000317:Adrenergic alpha-Antagonists; D006360:Heat-Shock Proteins; D017292:Doxazosin